Cytokines and hemostasis

Haematologica

Volumn 85, Issue 9, 2000, Pages 967-972

  Grignani, G ^a   Maiolo, A ^a  

^a Department of Internal Medicine   (Italy)

Author keywords

Cytokines; Endothelial cells; Hemostasis; Monocytes; Tissue factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD CLOTTING; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; IMMUNOREGULATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMAL; BLOOD COAGULATION DISORDERS; CYTOKINES; FIBRINOLYTIC AGENTS; HEMOSTASIS; HEMOSTATICS; HUMAN; THROMBOPLASTIN;

EID: 0033790858     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. The structural biology of expression and function of tissue factor
2. Tissue factor: Then and now
3. The structural basis of function of the TF.VIIa complex in the cellular initiation of coagulation
4. Some thoughts about localization and expression of tissue factor
5. Initiation of blood coagulation: The tissue factor/factor VIIa complex
6. Crystal structure of the extracellular region of human tissue factor
7. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site
8. Human factor VIIa and its complex with soluble tissue factor: Evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods
9. The tissue factor pathway: How it has become a 'prima ballerina'
10. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor
11. Tissue factor signalling
12. Cellular consequences of the initiation of blood coagulation
13. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation
14. Endothelial cells in physiology and in the pathophysiology of vascular disorders
15. Cell-cell interaction and tissue factor expression
16. Endothelial cell function, including tissue factor expression, under flow conditions
17. Tissue factor modulation of factor VIIa activity: Use in measuring trace levels of factor VIIa in plasma
18. Tissue factor expression in human leukocytes and tumor cells
19. Cytokines and thrombosis
20. The immunotherapeutic potential of the monocyte
21. Cytokines: Triggers of clinical thrombotic disease
22. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13
23. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity
24. Augmented procoagulant activity in cancer patients, treated with recombinant interferon-γ in addition to recombinant tumor necrosis factor-α and melphalan
25. Expression of leukocyte integrins and tissue factor in mononuclear phagocytes
26. Heterogeneity of procoagulant activity and cytokine release in subpopulations of alveolar macrophages and monocytes
27. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: Induction of collagenase, stromelysin, and tissue factor
28. Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells
29. Cytokine activation of endothelial cells: New molecules for an old paradigm
30. Monocytes upregulate endothelial cell expression of tissue factor: A role for cell-cell contact and cross-talk
31. Vascular endothelium dysfunction
32. Advanced glycosylation end-products and the pathogenesis of accelerated atherosclerosis in diabetes
33. NFkB prevents apoptosis and liver dysfunction during liver regeneration
34. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity
35. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression
36. Disseminated intravascular coagulation
37. The pathophysiology of disseminated intravascular coagulation
38. Neutrophils express tissue factor in a monkey model of sepsis
39. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
40. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees
41. Elimination of interleukin-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees
42. Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees
43. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans
44. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, to neutrophil degranulation and the release of sPLA2 in sepsis. Studies in non-human primates after interleukin-1α administration and during lethal bacteremia
45. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis
46. IL-10 controls IFN-γ and TNF production during experimental endotoxemia
47. Thrombosis in primary antiphospholipid syndrome: A pivotal role for monocyte tissue factor expression
48. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome
49. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome
50. High plasma levels of tumor necrosis factor-α may be predictive of veno-occlusive disease in bone marrow transplantation
51. Venocclusive disease of the liver after bone marrow transplantation: The role of hemostasis
52. Transient intermittent lymphocyte activation is responsible for the instability of angina
53. Cytokine gene expression in human LPS- and IFNγ-stimulated mononuclear cells is inhibited by heparin
54. Epidemiological evidence for inflammation in cardiovascular disease
55. Elevation of circulating interleukin-6 after surgery: Factors influencing the serum level
56. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells
57. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection
58. Human heart endothelial cell-restricted allorecognition
59. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation
60. Activation of blood coagulation in cancer: Trousseau's syndrome revisited
61. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: Results from a randomized trial
62. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism
63. Tissue factor-dependent activation of platelets by cells and microvesicles of SKOS-10 human osteogenic sarcoma cell line
64. Different expression of procoagulant activity in human cancer cells cultured in vitro or in cells isolated from human tumor tissues
65. Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue
66. Human breast and colon carcinomas express cysteine proteinase activities with pro-aggregating and pro-coagulant properties
67. Tumor-associated macrophages
68. The importance of blood cell-vessel wall interactions in tumor metastasis
69. Features of the cytokines secreted by adult T cell leukemia (ATL) cells
70. Tumor-host interaction: Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas
71. Interleukin-1 increases expression of the LYT-10 (NFkB2) proto-oncogene/transcription factor in renal cell carcinoma lines
72. Circulating interleukin-6 levels are elevated in adult T-cell leukemia/lymphoma patients and correlate with adverse clinical features and survival
73. Effect of interferon alpha, interferon gamma and tumor necrosis factor on the procoagulant activity of human cancer cells
74. Procoagulant activity of tumor cells and its modulation by different cytokines
75. Tumor cells induce the expression of tissue factor-like procoagulant activity on endothelial cells
76. Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor
77. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon Gram-negative model of septic shock
78. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa
79. Hemostatic parameters in sepsis patients treated with anti-TNF alpha-monoclonal antibodies
80. Effect of dexamethasone on interleukin-1 beta-(IL-1 beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells
81. Effect of FR1676S3, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation